{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:25Z","timestamp":1786120345935,"version":"build-2736575974"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/bor.0b013e3283526509","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T05:09:10Z","timestamp":1332911350000},"page":"261-266","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic plasma exchange in systemic vasculitis"],"prefix":"10.1097","volume":"24","author":[{"given":"Alfred","family":"Mahr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verin","family":"Chaigne-Delalande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"De Menthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210128","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJM199711203372106","article-title":"Small-vessel vasculitis.","volume":"337","author":"Jennette","year":"1997","journal-title":"N Engl J Med"},{"key":"R2-4-20210128","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(97)80118-3","article-title":"Primary systemic vasculitis.","volume":"349","author":"Savage","year":"1997","journal-title":"Lancet"},{"key":"R3-4-20210128","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/bmj.2.5965.252","article-title":"Recovery from Goodpastures syndrome after immunosuppressive treatment and plasmapheresis.","volume":"2","author":"Lockwood","year":"1975","journal-title":"Br Med J"},{"key":"R4-4-20210128","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1744-9987.2011.00930.x","article-title":"Theoretical basis of pathogenic substance removal during plasmapheresis.","volume":"15","author":"Hanafusa","year":"2011","journal-title":"Ther Apher Dial"},{"key":"R5-4-20210128","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jca.20302","article-title":"Conventional apheresis therapies: a review.","volume":"26","author":"Ward","year":"2011","journal-title":"J Clin Apher"},{"key":"R6-4-20210128","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1744-9987.2005.00319.x","article-title":"Complications of therapeutic plasma exchange: experience with 4857 treatments.","volume":"9","author":"Basic-Jukic","year":"2005","journal-title":"Ther Apher Dial"},{"key":"R7-4-20210128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2008.09.003","article-title":"World apheresis registry 2003-2007 data.","volume":"39","author":"Stegmayr","year":"2008","journal-title":"Transfus Apher Sci"},{"key":"R8-4-20210128","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0031-1279829","article-title":"Pulmonary: renal syndrome with a focus on anti-GBM disease.","volume":"32","author":"Sanders","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"R9-4-20210128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ki.1973.14","article-title":"Antiglomerular basement membrane antibody-induced glomerulonephritis.","volume":"3","author":"Wilson","year":"1973","journal-title":"Kidney Int"},{"key":"R10-4-20210128","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00005792-198507000-00003","article-title":"Therapy of antiglomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors.","volume":"64","author":"Johnson","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MD.0b013e31822f6f68","article-title":"Antiglomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese Cohort Study.","volume":"90","author":"Cui","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"R12-4-20210128","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.7326\/0003-4819-134-11-200106050-00009","article-title":"Long-term outcome of antiglomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.","volume":"134","author":"Levy","year":"2001","journal-title":"Ann Intern Med"},{"key":"R13-4-20210128","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis.","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R14-4-20210128","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis.","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R15-4-20210128","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2010.10.049","article-title":"Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis.","volume":"57","author":"Walsh","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R16-4-20210128","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ndt\/gfq360","article-title":"Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegeners granulomatosis: a clinical randomized controlled trial.","volume":"26","author":"Szpirt","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R17-4-20210128","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis.","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R18-4-20210128","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1053\/j.ajkd.2003.08.015","article-title":"Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis.","volume":"42","author":"Klemmer","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R19-4-20210128","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/SMJ.0b013e3180f62d0f","article-title":"Henoch-Schonlein purpura: a review article.","volume":"100","author":"Roberts","year":"2007","journal-title":"South Med J"},{"key":"R20-4-20210128","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/adc.75.3.186","article-title":"Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis.","volume":"75","author":"Gianviti","year":"1996","journal-title":"Arch Dis Child"},{"key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s00467-004-1514-0","article-title":"Plasmapheresis therapy for rapidly progressive Henoch-Schonlein nephritis.","volume":"19","author":"Kawasaki","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"R22-4-20210128","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00467-008-0886-y","article-title":"Successful treatment of gastrointestinal involvement in Henoch-Schonlein purpura with plasmapheresis.","volume":"23","author":"Acar","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R23-4-20210128","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1080\/08035250500509180","article-title":"Refractory severe intestinal vasculitis due to Henoch-Schonlein purpura: successful treatment with plasmapheresis.","volume":"95","author":"Wortmann","year":"2006","journal-title":"Acta Paediatr"},{"key":"R24-4-20210128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000223237","article-title":"Life-threatening or organ-impairing Henoch-Schonlein purpura: plasmapheresis may save lives and limit organ damage.","volume":"219","author":"Donghi","year":"2009","journal-title":"Dermatology"},{"key":"R25-4-20210128","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0272-6386(99)70178-2","article-title":"Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schonlein purpura nephritis in children.","volume":"33","author":"Hattori","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R26-4-20210128","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00467-007-0498-y","article-title":"Treating severe Henoch-Schonlein and IgA nephritis with plasmapheresis alone.","volume":"22","author":"Shenoy","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"R27-4-20210128","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.autrev.2011.01.008","article-title":"Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.","volume":"10","author":"Pietrogrande","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"Suppl 1","key":"R28-4-20210128","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/S1590-8658(07)80027-2","article-title":"Plasmapheresis in cryoglobulinemic neuropathy: a clinical study.","volume":"39","author":"Scarpato","year":"2007","journal-title":"Dig Liver Dis"},{"key":"R29-4-20210128","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jca.20222","article-title":"Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of complicated HCV-related cryoglobulinemia.","volume":"24","author":"Stefanutti","year":"2009","journal-title":"J Clin Apher"},{"key":"R30-4-20210128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2010.03.001","article-title":"Plasma exchange for treating cryoglobulinemia: a descriptive analysis.","volume":"42","author":"Rockx","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"R31-4-20210128","first-page":"289","article-title":"Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges: a prospective trial in 33 patients.","volume":"20","author":"Guillevin","year":"1993","journal-title":"J Rheumatol"},{"key":"R32-4-20210128","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/ard.53.5.334","article-title":"Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges.","volume":"53","author":"Guillevin","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"R33-4-20210128","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/art.20401","article-title":"Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa.","volume":"51","author":"Guillevin","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R34-4-20210128","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/rheumatology\/40.9.1064","article-title":"Successful treatment of hepatitis B-associated vasculitis using lamivudine as the sole therapeutic agent.","volume":"40","author":"Filer","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"R35-4-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients.","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"R36-4-20210128","first-page":"79","article-title":"Trial of prevention of coronary aneurysm in Kawasakis disease using plasma exchange or infusion of immunoglobulins French.","volume":"44","author":"Villain","year":"1987","journal-title":"Arch Fr Pediatr"},{"key":"R37-4-20210128","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1442-200X.2011.03487.x","article-title":"Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease.","volume":"54","author":"Hokosaki","year":"2012","journal-title":"Pediatr Int"},{"key":"R38-4-20210128","first-page":"349","article-title":"Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin in Japanese.","volume":"66","author":"Mori","year":"2008","journal-title":"Nihon Rinsho"},{"key":"R39-4-20210128","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00431-003-1267-y","article-title":"Plasma exchange for refractory Kawasaki disease.","volume":"163","author":"Imagawa","year":"2004","journal-title":"Eur J Pediatr"},{"key":"R40-4-20210128","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0140-6736(95)91916-3","article-title":"Plasma exchange in Kawasaki disease.","volume":"346","author":"Takagi","year":"1995","journal-title":"Lancet"},{"key":"R41-4-20210128","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1744-9987.2008.00566.x","article-title":"A report of two cases of Kawasaki disease treated with plasma exchange.","volume":"12","author":"Harada","year":"2008","journal-title":"Ther Apher Dial"},{"key":"R42-4-20210128","first-page":"198","article-title":"Treatment of glomerulonephritis in microscopic polyangiitis and Churg-Strauss syndrome. Indications of plasma exchanges, Meta-analysis of 2 randomized studies on 140 patients, 32 with glomerulonephritis.","volume":"148","author":"Guillevin","year":"1997","journal-title":"Ann Med Interne (Paris)"},{"key":"R43-4-20210128","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/art.1780350214","article-title":"Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome: a prospective, randomized trial in 78 patients.","volume":"35","author":"Guillevin","year":"1992","journal-title":"Arthritis Rheum"},{"key":"R44-4-20210128","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/art.1780381116","article-title":"Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis: a prospective, randomized trial in sixty-two patients.","volume":"38","author":"Guillevin","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R45-4-20210128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF02169413","article-title":"Plasma exchange in the therapy of Behcets disease.","volume":"227","author":"Raizman","year":"1989","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R46-4-20210128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0248-8663(83)80021-6","article-title":"Plasma exchange in the treatment of Behcets disease: preliminary study apropos of 7 cases French.","volume":"4","author":"You","year":"1983","journal-title":"Rev Med Interne"},{"key":"R47-4-20210128","first-page":"15","article-title":"Plasma exchange and acyclovir in Behcets disease in French.","volume":"9","author":"Bonnet","year":"1986","journal-title":"J Fr Ophtalmol"},{"key":"R48-4-20210128","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0190-9622(89)80234-8","article-title":"Behcets disease with severe cutaneous necrotizing vasculitis: response to plasma exchange - report of a case.","volume":"21","author":"Cornelis","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"R49-4-20210128","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0190-9622(08)81026-2","article-title":"Plasma exchange in patients with Behcets disease.","volume":"22","author":"Lambert","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"R50-4-20210128","first-page":"331","article-title":"Treatment of severe Behcets disease by plasma exchange with or without immunosuppressive drugs: long term follow-up.","volume":"337","author":"Rifle","year":"1990","journal-title":"Prog Clin Biol Res"},{"key":"R51-4-20210128","first-page":"26","article-title":"Extracorporeal circulation methods in the treatment of nonspecific aortic arteritis in Russian.","volume":"70","author":"Belova","year":"1998","journal-title":"Ter Arkh"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e3283526509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:35:02Z","timestamp":1786048502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-201205000-00004"}},"subtitle":["an update on indications and results"],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3283526509","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}